In vivo gene editing for lipid management: An early perspective from ANGPTL3-targeted CRISPR-Cas9 therapy

Molecular Therapy 2026 Open access

Read full text

Authors: Luke Joseph Laffin, Steven E. Nissen

DOI: 10.1016/j.ymthe.2025.12.046

Cited by: 0

References: 9

Fields of Study & Subjects

Lipid metabolism and disorders CRISPR and Genetic Engineering Lipid metabolism and biosynthesis

References 9